Collegium Pharmaceutical (COLL) Goodwill & Intangibles (2016 - 2026)

Collegium Pharmaceutical's Goodwill & Intangibles history runs 11 years deep, the most recent figure standing at $760.0 million for Q1 2026.

• On a quarterly basis, Goodwill & Intangibles fell 22.98% year-over-year to $760.0 million in Q1 2026; TTM through Mar 2026 was $760.0 million, a 22.98% decrease from a year earlier, with the FY2025 full-year figure at $815.4 million, down 22.61% from the prior year.
• Goodwill & Intangibles declined to $760.0 million in Q1 2026 per COLL's latest filing, from $815.4 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $1.1 billion in Q1 2022 and bottomed at $486.5 million in Q2 2024.
• The 5-year median for Goodwill & Intangibles is $870.9 million (2025), against an average of $843.8 million.
• Across the five-year window, Goodwill & Intangibles soared 280.45% in 2022 and sank 51.98% in 2024, its largest moves.
• Year by year, Goodwill & Intangibles stood at $701.2 million in 2022, then declined by 20.77% to $555.6 million in 2023, then soared by 89.67% to $1.1 billion in 2024, then retreated by 22.61% to $815.4 million in 2025, then declined by 6.8% to $760.0 million in 2026.
• Per Business Quant, the three latest COLL Goodwill & Intangibles figures stand at $760.0 million (Q1 2026), $815.4 million (Q4 2025), and $870.9 million (Q3 2025).